Swiss National Bank’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.75M Hold
40,000
﹤0.01% 1763
2026
Q1
$2.57M Buy
40,000
+400
+1% +$36.5K ﹤0.01% 1729
2025
Q4
$5.15M Buy
39,600
+3,700
+10% +$508K ﹤0.01% 1332
2025
Q3
$3.87M Sell
35,900
-1,600
-4% -$174K ﹤0.01% 1465
2025
Q2
$3.46M Buy
37,500
+5,600
+18% +$440K ﹤0.01% 1483
2025
Q1
$2.83M Buy
31,900
+8,100
+34% +$703K ﹤0.01% 1574
2024
Q4
$1.83M Buy
23,800
+3,400
+17% +$237K ﹤0.01% 1906
2024
Q3
$866K Buy
+20,400
New +$689K ﹤0.01% 2280
2023
Q1
Sell
-8,133
Closed -$70.8K 2671
2022
Q4
$70.8K Hold
8,133
﹤0.01% 2677
2022
Q3
$236K Buy
8,133
+1,142
+16% +$52.3K ﹤0.01% 2685
2022
Q2
$291K Sell
6,991
-788
-10% -$53.5K ﹤0.01% 2712
2022
Q1
$788K Buy
7,779
+573
+8% +$63.7K ﹤0.01% 2492
2021
Q4
$1.06M Buy
+7,206
New +$1.61M ﹤0.01% 2444

Other funds holding WGS

Swiss National Bank's WGS Position: Q2 2026 in Review

Swiss National Bank held its GeneDx Holdings (WGS) position steady in Q2 2026 at 40,000 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

Swiss National Bank first reported a position in WGS in Q4 2021 and has held it in 13 quarters since. The position peaked at $5.15M in Q4 2025. 137 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Swiss National Bank held 40,000 shares of GeneDx Holdings worth $2.75M as of Q2 2026.
  • Swiss National Bank left its GeneDx Holdings share count unchanged in Q2 2026.
  • GeneDx Holdings made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1763 holding.
  • Swiss National Bank first reported a position in GeneDx Holdings in Q4 2021 and has held it in 13 quarters since.
  • Swiss National Bank's GeneDx Holdings position peaked at $5.15M in Q4 2025.
  • 137 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.